Aquaculture Vaccines Market: By Vaccine Type (Inactivated Vaccine, Attenuated Live Vaccine, DNA Vaccine, and Others), By Application (Bacterial Infection, Viral Infections, Combined Bacterial and Viral Infections, and Others), By Route of Administration (Immersion Vaccines, Injection Vaccines, and Oral Vaccines), By Species (Salmon, Seabass and Seabream, Tilapia, Trout, Turbot, and Carp), and Geography (North America, Latin America, Europe, Asia Pacific and Middle East and Africa)


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Aquaculture Vaccine Market is valued at USD 482.6 million in 2022 and is projected to reach 817.8 million by 2029, at a CAGR of 7.9% from 2023-29. Due to surge in the of prevalence of bacterial and viral infections among aquaculture species, increase in aquaculture production around the globe, and rise in adoption of vaccines by aquaculture farmers. Development and launch of innovative vaccines to treat various infectious diseases in aquaculture species boosting the revenue growth of the market. For instance, In March 2018, Hipra launched Icthiovac VR/PD injectable vaccine for seabass against Vibriosis and Pasteurellosis in Greece. Apart from the aforementioned dynamics, Raise in funding for the research and development of innovative aquaculture vaccines boost the market over forecast years. For instance, In March 2015, The Scottish Aquaculture Innovation Center (SAIC) has announced it is issuing grants worth almost GBP 950,000 to two major salmon farming research projects proposed by leading farmed salmon companies on sea lice and salmon vaccinations.   

Aquaculture Vaccine Market Key Development:
  • In April 2021, CIBA launched Nodavac-R, an injectable recombinant viral nervous necrosis (VNN) vaccine that can effectively prevent VNN caused by RGNNV in fingerlings and prevent vertical transmission in brooders. All fish species, including milkfish, grey mullet, and mangrove red snapper susceptible to VNN, can use the Nodavac-R. CIBA is also developing an oral vaccine that can administer through feed and immersion.
  • In November 2019, MSD Animal Health launched the AQUAVAC® Strep Sa-Si injectable and dip immersion vaccine against Streptococcis in tilapia fish in Latin America.

Global Aquaculture Vaccines Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

Latin America
Aquaculture Vaccine Market Dynamics

Increase in the fish mortality due to certain disease outbreaks driving the growth of aquaculture vaccines market. For instance, in October 2017, approximately 125,000 salmon have died due to a disease outbreak at two fish farms on the Isle of Lewis due to bacterium Pasturella Skyensis infection. In addition, surge in population demand for the healthy fish products, demand for animal protein, government support for the aquaculture immunization programs, rise in adoption of aquaculture vaccines in the developed and developing nations are boost the aquaculture vaccines market over the forecast years. Moreover, increase in the international trading of aquaculture species immense boost the global aquaculture vaccines over the forecast period.

Key Features of the Reports

  • The aquaculture vaccine market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Aquaculture Vaccines Market Segmentation

By Vaccine Type
  • Inactivated Vaccine
  • Attenuated Live Vaccine
  • DNA Vaccine
  • Others
By Application
  • Bacterial Infection
  • Viral Infection
  • Combined Bacterial and Viral Infections
  • Others
By Route of Administ
  • Immersion Vaccines
  • Injection Vaccines
  • Oral Vaccines
By Species
  • Salmon
  • Seabass and Seabream
  • Tilapia
  • Trout
  • Turbot
  • Carp

Frequently Asked Questions

The global aquaculture vaccine market is valued at USD 482.6 million in 2022 and is projected to reach 817.8 million by 2029.

The CAGR of the aquaculture vaccines market is 7.6% over the forecast period (2022 - 2028)

Inactivated vaccine type dominates the aquaculture vaccine product segment.

Norway is the big market in the aquaculture vaccines market

Zoetis (Pharmaq), MSD Animal Health, Elanco, and Virbac are the key market players in the aquaculture vaccines market.

  • Pharmaq AS (Zoetis, LLC) (Norway)
  • Merck Animal Health (Merck & Co., Inc.) (USA)
  • KoVax Ltd. (Part of Phibro Animal Health) (Israel)
  • Hipra (Spain)
  • Tecnovax SA (Argentina)
  • Veterquimica S.A. (Chile)
  • Nisseiken Co. Ltd. (Japan)
  • Virbac S.A. (France)
  • Elanco (USA)
  • Kyoritsuseiyaku Corporation (Japan)